-
The Food and Drug Administration (FDA) has revised labeling on the contraceptive patch (Ortho Evra, Ortho-McNeil-Janssen Pharmaceuticals; Raritan, NJ) to include new epidemiology data on the risks of venous thromboembolism (VTE).
-
Data released at a recent international conference suggest that adult male circumcision, which has been seen as possibly reducing the risk of HIV transmission in Africa, could raise the risk for women there whose male partners seek the procedure after they are infected.
-
Good news for your patients who use oral contraceptives (OCs): A new analysis of 45 epidemiological studies shows that use of such pills during a woman's lifetime gives substantial long-term protection against ovarian cancer.
-
Results of a new survey released by the National Association of Nurse Practitioners in Women's Health (NPWH) indicate that most of the 1,000 women polled often confused myth with fact when quizzed about cervical cancer prevention.
-
Patients seeking medication abortion using mifepristone (Mifeprex, Danco Group) may be asking questions after news agencies reported leukemia drug safety issues at a Chinese drug manufacturing firm that serves as the sole U.S. supplier of mifepristone.
-
A multidrug-resistant variant of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteria is emerging in cities on both coasts of the United States, according to data from a new California-led study.
-
Federal and state funding for family planning client services reached $1.85 billion in FY 2006, a 63% increase over 12 years, adjusting for inflation.
-
-
One of the resources being made available to the newly designated Chartered Value Exchanges, or CVEs, will be technical assistance provided by the Sacramento, CA-based Center for Health Improvement (CHI).
-
Mortality rates and hospital costs at facilities participating in the Centers for Medicare and Medicaid Services (CMS) pay-for-performance demonstration project continue to decline, according to analysis by the Premier health care alliance.
